BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextToU//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:13dcc1ef-783f-4fc0-9ce1-b3e12ef4c8a3@nexttoyou
DTSTAMP:20261106T163809Z
DTSTART:20261112T220000Z
DTEND:20261112T233000Z
SUMMARY:Pediatric CRISPR Therapy for Sickle Cell and Beta-Thalassemia with
  Dr. Haydar Frangoul\, MD
LOCATION:FCOM 2201
DESCRIPTION:Journal Club's first meeting of the year will be with Dr. Hayd
 ar Frangoul from the Sarah Cannon Institute at Tristar Centennial\, who h
 as been an integral part of gaining FDA approval for Casgevy\, expanding 
 treatment options for children with sickle cell anemia and transfusion-de
 pendent beta-thalassemia.\n\nhttp://next-to-u.app/events/13dcc1ef-783f-4f
 c0-9ce1-b3e12ef4c8a3
URL:http://next-to-u.app/events/13dcc1ef-783f-4fc0-9ce1-b3e12ef4c8a3
END:VEVENT
END:VCALENDAR